November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Jean-Charles Soria: Limiting ecDNA evolution could open impactful new therapeutic horizons
Nov 11, 2024, 17:39

Jean-Charles Soria: Limiting ecDNA evolution could open impactful new therapeutic horizons

 Clinical Research Fellow at Cancer Evolution and Genome Instability Laboratory, was mentioned by 

“EcDNA fuels cancer progression: large, mobile circles of DNA in tumors drive high oncogene copies and rapid genetic changes. Their random spread during cell division increases treatment resistance and tumor evolution.

Determining therapeutic vulnerabilities and identifying target compounds to limit ecDNA evolution could open impactful new therapeutic horizons.”

“Origins and impact of extrachromosomal DNA”

Authors: Chris Bailey, Oriol Pich, Kerstin Thol, Mariam Jamal-Hanjani, Charles Swanton et al.

Jean-Charles Soria: Limiting ecDNA evolution could open impactful new therapeutic horizons

More posts featuring Jean-Charles Soria.

Jean-Charles Soria serves as Amgen’s senior vice president of Oncology within Global Development. He is a medical oncologist and a professor of medicine at Paris-Saclay University. From 2017 to 2019, he was the senior vice president of Research and Development in Oncology at AstraZeneca. Additionally, Soria has authored or co-authored over 670 articles in leading international journals and has been recognized as one of the world’s most influential research scientists.